Desai Neil 的 Form 4 申報
Whitehawk Therapeutics, Inc.（WHWK），2023/4/5 申報
- 申報編號
- 0001209191-23-023483
- 申報時間
- 2023/4/5
- 交易日
- 2023/4/3-4/5
- 申報延遲
- 2 天
- 10b5-1 計畫
- 沒有勾選
這份申報列了 3 筆非衍生性交易。公開市場賣出合計 $21.8 萬。交易後 2 天申報。
申報人
一份 Form 4 可以有好幾位申報人，例如本人與他控制的基金。各交易表上顯示的是第一位。
| 申報人 | 與公司的關係 |
|---|---|
| Desai NeilCIK 0001878692 | 董事、高階主管（執行董事長）、持股 10% 以上大股東 |
非衍生性證券（表 I）
普通股等股票的取得與處分，每一列是申報上的一筆。
附註與備註
本站收錄交易價格引用的附註、修正申報（Form 4/A）的全部附註，以及申報的備註。其他附註，例如間接持有的方式、交易計畫的細節，請看 SEC EDGAR 上的原文。
- F2
Represents the weighted average share price of an aggregate total of 9,583 shares sold in the price range of $7.29 to $7.59 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
表 I 有 1 筆交易的價格引用這則附註。
- F4
Represents the weighted average share price of an aggregate total of 12,869 shares sold in the price range of $7.20 to $7.40 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
表 I 有 1 筆交易的價格引用這則附註。
- F5
Represents the weighted average share price of an aggregate total of 7,336 shares sold in the price range of $7.20 to $7.37 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
表 I 有 1 筆交易的價格引用這則附註。